MedTrace Logo

Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC

NCT05741073 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1300

Last updated 2025-03-12

No results posted yet for this study

Summary

This current registry study will analyze real-world data to address questions about disease characteristics and treatment patterns in NMSC patients based on the European NMSC-Registry. The overall objective is to describe characteristics, management and treatment outcomes for patients presenting with advanced NMSC (cSCC/BCC) or HR-cSCC in routine clinical practice, independent of treatments used across different European regions.

Conditions

Sponsors & Collaborators

  • EuMelaReg gGmbH

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-30
Primary Completion
2027-06-30
Completion
2027-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05741073 on ClinicalTrials.gov